Global Human Rabies Immunoglobulin (IM) Market Survey and Trend Research 2018

September 2018 | 68 pages | ID: GA5F77EEB55EN
99Strategy

Abstracts

Summary

Rabies immunoglobulin (RIG) is a medication made up of antibodies against the rabies virus. It is used to prevent rabies following exposure.

This report describes the development of the industry by upstream & downstream, industry overall and development, key companies, as well as type segment & market application and so on, and makes a scientific prediction for the development industry prospects on the basis of analysis, finally, analyzes opportunities for investment in the industry at the end of the report.

Industry Chain

• Raw Materials
• Cost
• Technology
• Consumer Preference

Industry Overall:

• History
• Development & Trend
• Market Competition
• Trade Overview
• Policy

Region (North America, Europe, Asia-Pacific, South America, Middle East, Africa):

• Regional Market
• Production Development
• Sales
• Regional Trade
• Regional Forecast

Company (CSL Behring, Grifols , Sanofi, Sichuan Yuanda Shuyang, Kamada, Kamada, CBPO, Shuanglin Bio, Weiguang Bio, Shanghai RAAS, Bharat Serum, VINS etc.):

• Company Profile
• Product & Service
• Business Operation Data
• Market Share

Investment Analysis:

• Market Features
• Investment Opportunity
• Investment Calculation

Contents

PART 1 INDUSTRY OVERVIEW

1.1 Human Rabies Immunoglobulin (IM) Industry
  1.1.1 Definition
  1.1.2 Industry Trend
1.2 Industry Chain
  1.2.1 Upstream
  1.2.2 Technology
  1.2.3 Cost Structure
  1.2.4 Consumer Preference
  1.2.2 Downstream

PART 2 INDUSTRY OVERALL

2.1 Industry History
2.2 Development Prospect
2.3 Competition Structure
2.4 Relevant Policy
2.5 Trade Overview

PART 3 HUMAN RABIES IMMUNOGLOBULIN (IM) MARKET BY PRODUCT

3.1 Products List of Major Companies
3.2 Market Size
3.3 Market Forecast

4 KEY COMPANIES LIST

4.1 CSL Behring (Company Overview, Sales Data etc.)
  4.1.1 Company Overview
  4.1.2 Products and Services
  4.1.3 Business Analysis
4.2 Grifols (Company Overview, Sales Data etc.)
  4.2.1 Company Overview
  4.2.2 Products and Services
  4.2.3 Business Analysis
4.3 Sanofi (Company Overview, Sales Data etc.)
  4.3.1 Company Overview
  4.3.2 Products and Services
  4.3.3 Business Analysis
4.4 Sichuan Yuanda Shuyang (Company Overview, Sales Data etc.)
  4.4.1 Company Overview
  4.4.2 Products and Services
  4.4.3 Business Analysis
4.5 Kamada (Company Overview, Sales Data etc.)
  4.5.1 Company Overview
  4.5.2 Products and Services
  4.5.3 Business Analysis
4.6 Kamada (Company Overview, Sales Data etc.)
  4.6.1 Company Overview
  4.6.2 Products and Services
  4.6.3 Business Analysis
4.7 CBPO (Company Overview, Sales Data etc.)
  4.7.1 Company Overview
  4.7.2 Products and Services
  4.7.3 Business Analysis
4.8 Shuanglin Bio (Company Overview, Sales Data etc.)
  4.8.1 Company Overview
  4.8.2 Products and Services
  4.8.3 Business Analysis
4.9 Weiguang Bio (Company Overview, Sales Data etc.)
  4.9.1 Company Overview
  4.9.2 Products and Services
  4.9.3 Business Analysis
4.10 Shanghai RAAS (Company Overview, Sales Data etc.)
  4.10.1 Company Overview
  4.10.2 Products and Services
  4.10.3 Business Analysis
4.11 Bharat Serum (Company Overview, Sales Data etc.)
4.12 VINS (Company Overview, Sales Data etc.)

PART 5 MARKET COMPETITION

5.1 Companies Competition
5.2 Industry Competition Structure Analysis
  5.2.1 Rivalry
  5.2.2 Threat of New Entrants
  5.2.3 Substitutes
  5.2.4 Bargaining Power of Suppliers
  5.2.5 Bargaining Power of Buyers

PART 6 MARKET DEMAND BY SEGMENT

6.1 Demand Situation
  6.1.1 Industry Application Status
  6.1.2 Industry SWOT Analysis
    6.1.2.1 Strengths
    6.1.2.2 Weaknesses
    6.1.2.3 Opportunities
    6.1.2.4 Threats
6.2 Major Customer Survey
6.3 Demand Forecast

PART 7 REGION OPERATION

7.1 Regional Market
7.2 Production and Sales by Region
  7.2.1 Production
  7.2.2 Sales
  7.2.3 Trade
7.3 Regional Forecast

PART 8 MARKET INVESTMENT

8.1 Market Features
  8.1.1 Product Features
  8.1.2 Price Features
  8.1.3 Channel Features
  8.1.4 Purchasing Features
8.2 Investment Opportunity
  8.2.1 Regional Investment Opportunity
  8.2.2 Industry Investment Opportunity
8.3 Investment Calculation
  8.3.1 Cost Calculation
  8.3.2 Revenue Calculation
  8.3.3 Economic Performance Evaluation

PART 9 CONCLUSION

List Of Tables

LIST OF TABLES

Table Global Human Rabies Immunoglobulin (IM) Market 2012-2017, by Type, in USD Million
Table Global Human Rabies Immunoglobulin (IM) Market Forecast 2018-2023, by Type, in USD Million
Table CSL Behring Overview List
Table Human Rabies Immunoglobulin (IM) Business Operation of CSL Behring (Sales Revenue, Cost, Gross Margin)
Table Grifols Overview List
Table Human Rabies Immunoglobulin (IM) Business Operation of Grifols (Sales Revenue, Cost, Gross Margin)
Table Sanofi Overview List
Table Human Rabies Immunoglobulin (IM) Business Operation of Sanofi (Sales Revenue, Cost, Gross Margin)
Table Sichuan Yuanda Shuyang Overview List
Table Human Rabies Immunoglobulin (IM) Business Operation of Sichuan Yuanda Shuyang (Sales Revenue, Cost, Gross Margin)
Table Kamada Overview List
Table Human Rabies Immunoglobulin (IM) Business Operation of Kamada (Sales Revenue, Cost, Gross Margin)
Table Kamada Overview List
Table Human Rabies Immunoglobulin (IM) Business Operation of Kamada (Sales Revenue, Cost, Gross Margin)
Table CBPO Overview List
Table Human Rabies Immunoglobulin (IM) Business Operation of CBPO (Sales Revenue, Cost, Gross Margin)
Table Shuanglin Bio Overview List
Table Human Rabies Immunoglobulin (IM) Business Operation of Shuanglin Bio (Sales Revenue, Cost, Gross Margin)
Table Weiguang Bio Overview List
Table Human Rabies Immunoglobulin (IM) Business Operation of Weiguang Bio (Sales Revenue, Cost, Gross Margin)
Table Shanghai RAAS Overview List
Table Human Rabies Immunoglobulin (IM) Business Operation of Shanghai RAAS (Sales Revenue, Cost, Gross Margin)
Table Bharat Serum Overview List
Table Human Rabies Immunoglobulin (IM) Business Operation of Bharat Serum (Sales Revenue, Cost, Gross Margin)
Table VINS Overview List
Table Human Rabies Immunoglobulin (IM) Business Operation of VINS (Sales Revenue, Cost, Gross Margin)
Table Global Human Rabies Immunoglobulin (IM) Sales Revenue 2012-2017, by Companies, in USD Million
Table Global Human Rabies Immunoglobulin (IM) Sales Revenue Share, by Companies, in USD Million
Table Human Rabies Immunoglobulin (IM) Demand 2012-2017, by Application, in USD Million
Table Human Rabies Immunoglobulin (IM) Demand Forecast 2018-2023, by Application, in USD Million
Table Global Human Rabies Immunoglobulin (IM) Market 2012-2017, by Region, in USD Million
Table Human Rabies Immunoglobulin (IM) Market Forecast 2018-2023, by Region, in USD Million

List Of Figures

LIST OF FIGURES

Figure Human Rabies Immunoglobulin (IM) Industry Chain Structure
Figure Global Human Rabies Immunoglobulin (IM) Market Growth 2012-2017, by Type, in USD Million
Figure Global Human Rabies Immunoglobulin (IM) Sales Revenue Share, by Companies in 2017, in USD Million
Figure Production Development by Region
Figure Sales List by Region